HLA-C and neoplasm: After bioinformatics analyses of somatic mutations and prediction of MHC presentation, we validated a novel somatic insert frameshift variation in BAP1. The antibody of this neo-antigen succeeded to differentiate the tumor cells from normal cells during pathological diagnosis.